Experienced in Hemolysis

Dr. Ifeyinwa M. Osunkwo

Pediatrics | Hematology | Oncology
201 E Grover St, 
Shelby, NC 
Experienced in Hemolysis
201 E Grover St, 
Shelby, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ifeyinwa Osunkwo is a Pediatrics specialist and a Hematologist in Shelby, North Carolina. Dr. Osunkwo is rated as an Experienced provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Her clinical research consists of co-authoring 46 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatrics
Hematology
Oncology
Licenses
Pediatrics in NC
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

201 E Grover St, Shelby, NC 28150
Other Locations
15830 Ballantyne Medical Pl, Ste 200, Charlotte, NC 28277
1021 Morehead Medical Dr, Ste A, Charlotte, NC 28204
100 Medical Park Dr, Ste 110, Concord, NC 28025
945 N 5th St, Albemarle, NC 28001

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
A Phase III, Multicenter, Randomized, Double-blind Study to Assess Efficacy and Safety of Two Doses of Crizanlizumab Versus Placebo, With or Without Hydroxyurea/ Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patients With Vaso-Occlusive Crises (STAND)
Enrollment Status: Active_not_recruiting
Publish Date: September 24, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 3
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
A Prospective Phase II, Open-Label, Single-arm, Multicenter, Study to Assess Efficacy and Safety of SEG101 (Crizanlizumab), in Sickle Cell Disease Patients With Priapism (SPARTAN)
Enrollment Status: Completed
Publish Date: April 13, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
LCI-HEM-SCD-ST3P-UP-001: A Comparative Effectiveness Study of Peer Mentoring [PM] Versus Structured Transition Education Based Intervention [STE] for the Management of Care Transitions in Emerging Adults With Sickle Cell Disease (SCD)
LCI-HEM-SCD-ST3P-UP-001: A Comparative Effectiveness Study of Peer Mentoring [PM] Versus Structured Transition Education Based Intervention [STE] for the Management of Care Transitions in Emerging Adults With Sickle Cell Disease (SCD)
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
Enrollment Status: Completed
Publish Date: March 06, 2024
Intervention Type: Drug
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2
A Comparison of Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease
A Comparison of Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease
Enrollment Status: Terminated
Publish Date: July 03, 2023
Intervention Type: Other, Drug
Study Drugs: Morphine, Hydromorphone
Study Phase: Phase 3
View 5 Less Clinical Trials

46 Total Publications

Treatment Experience Using a Micro-Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease.
Treatment Experience Using a Micro-Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease.
Journal: Pediatric blood & cancer
Published: May 24, 2025
Similar Doctors
Payal C. Desai
Advanced in Hemolysis
Dr. Payal C. Desai
Hematology
Advanced in Hemolysis
Dr. Payal C. Desai
Hematology

Atrium Health Levine Cancer Institute

1021 Morehead Medical Drive, 
Charlotte, NC 
 (39.9 miles away)
980-442-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Payal Desai is a Hematologist in Charlotte, North Carolina. Dr. Desai is rated as an Elite provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Aspiration. Dr. Desai is currently accepting new patients.

Experienced in Hemolysis
Dr. Khine S. Shan
Hematology Oncology | Hematology | Oncology
Experienced in Hemolysis
Dr. Khine S. Shan
Hematology Oncology | Hematology | Oncology
300 E Mcbee Ave, Fl 4, 
Greenville, SC 
 (58.0 miles away)
Languages Spoken:
English
See accepted insurances

Khine Shan is a Hematologist Oncology specialist and a Hematologist in Greenville, South Carolina. Dr. Shan is rated as an Experienced provider by MediFind in the treatment of Hemolysis. Her top areas of expertise are Anemia, Hemolysis, Folate Deficiency, and Iron Deficiency Anemia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Osunkwo's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile